AcrySof™ IQ PanOptix™ Toric UV IOL TFAT60 (REF TFAT60.155)Recalls & reported problems

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00380652420204), received between Oct 21, 2022 and Oct 21, 2022 — classified as 1 injury.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

• InjuryOct 21, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

  A NON-HEALTHCARE PROFESSIONAL REPORTED THAT FOLLOWING THE INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE THE EXPERIENCED TERRIBLE PAIN DURING FIRST WEEK, EYE IS SORE MOST DAYS. THE PATIENT¿S MID AND CLOSE VISION WAS BLURRED ALL OF THE TIME. THE SURGEON SAID IT WAS DRY EYE. THE PATIENT USED SYSTANE DAILY HOWEVER NO RELIEF FROM PAIN AND SORENESS. ADDITIONAL INFORMATION RECEIVED AND STATED THAT, THE PATIENT HAD SEVERE PAIN, IRRITATION, AND SLIGHT WEEPING OR TEARING. THE PATIENT AGAIN STATED THAT HE HAD SORE EVERY DAY, IN THE LOWER RIGHT CORNER OF THE RIGHT EYE, IS VERY SORE DAILY AND MY EYE IS GLOSSY OR FILMY. THE PHYSICIAN. THE SURGEON HAD TOLD REPEATEDLY THAT THIS IS DRY EYE. THE SURGEON DID AN IRRITATION TEST ON BOTH EYES AND MY RIGHT EYE, HE CONCEDED, SHOWED INFLAMMATION. THE SURGEON TOLD ME TO USE RX PREDNISOLONE 1%.

  Patient problems: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available; Blurred Vision; Excessive Tear Production; Eye Pain; Inflammation; Irritability

  MAUDE report 15648872 ↗